Biotech Exec Lauds Bill To Ease Small-Company Disclosures
A bill to ease small companies' financial disclosure requirements drew plaudits at a House committee hearing Wednesday from a biotechnology executive worried about compliance costs, though skeptics cautioned that the proposal...To view the full article, register now.
Already a subscriber? Click here to view full article